Accel Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
10,265
-61
-0.6% -$1.6K 0.06% 253
2026
Q1
$290K Buy
10,326
+1,336
+15% +$35.6K 0.08% 219
2025
Q4
$224K Buy
8,990
+733
+9% +$18.5K 0.06% 255
2025
Q3
$210K Buy
+8,257
New +$204K 0.06% 263
2024
Q4
Sell
-8,148
Closed -$236K 262
2024
Q3
$236K Sell
8,148
-169
-2% -$4.93K 0.09% 212
2024
Q2
$233K Buy
8,317
+932
+13% +$25.7K 0.09% 201
2024
Q1
$205K Buy
+7,385
New +$205K 0.09% 213
2023
Q3
Sell
-5,931
Closed -$218K 177
2023
Q2
$218K Sell
5,931
-369
-6% -$14.4K 0.12% 154
2023
Q1
$257K Sell
6,300
-239
-4% -$10.3K 0.11% 181
2022
Q4
$335K Buy
6,539
+510
+8% +$24.5K 0.16% 111
2022
Q3
$268K Buy
6,029
+35
+0.6% +$1.7K 0.14% 133
2022
Q2
$310K Buy
5,994
+31
+0.5% +$1.58K 0.18% 107
2022
Q1
$308K Buy
5,963
+258
+5% +$13.4K 0.16% 111
2021
Q4
$337K Sell
5,705
-1,037
-15% -$51.4K 0.17% 107
2021
Q3
$290K Sell
6,742
-61
-0.9% -$2.7K 0.19% 92
2021
Q2
$266K Sell
6,803
-1,152
-14% -$44.8K 0.18% 113
2021
Q1
$288K Sell
7,955
-129
-2% -$4.58K 0.23% 88
2020
Q4
$298K Buy
+8,084
New +$297K 0.28% 75

Other funds holding PFE

Accel Wealth Management's PFE Position: Q2 2026 in Review

Accel Wealth Management reduced its Pfizer (PFE) stake by 0.59% in Q2 2026, selling an estimated $1.6K and leaving 10,265 shares worth $247K. The position accounts for 0.06% of the portfolio, ranked #253.

Accel Wealth Management first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $337K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Accel Wealth Management held 10,265 shares of Pfizer worth $247K as of Q2 2026.
  • Accel Wealth Management sold 61 Pfizer shares in Q2 2026, an estimated $1.6K.
  • Pfizer made up 0.06% of Accel Wealth Management's portfolio in Q2 2026, its #253 holding.
  • Accel Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
  • Accel Wealth Management's Pfizer position peaked at $337K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.